Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab and Lenalidomide in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide After Allo Transplant
- Status
- TERMINATED
- Phase
- PHASE1
SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients
- Status
- COMPLETED
- Phase
- PHASE1
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.
- Status
- COMPLETED
- Phase
- PHASE2
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2